Transcatheter Aortic Valve Replacement 2016: A Modern-Day "Through the Looking-Glass" Adventure.

[1]  C. Schmitt,et al.  A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  K. Kuck,et al.  1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.

[3]  A. Brickman,et al.  A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. , 2015, European heart journal.

[4]  M. Forsting,et al.  Intraaortic Protection From Embolization in Patients Undergoing Transaortic Transcatheter Aortic Valve Implantation. , 2015, The Annals of thoracic surgery.

[5]  M. Desai,et al.  Aortic annulus and root characteristics in severe aortic stenosis due to bicuspid aortic valve and tricuspid aortic valves: Implications for transcatheter aortic valve therapies , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  Hongyan Qiao,et al.  2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. , 2015, Journal of the American College of Cardiology.

[7]  Bin Duan,et al.  Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions , 2015, Expert opinion on biological therapy.

[8]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[9]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[10]  D. Capodanno,et al.  Early discharge after transfemoral transcatheter aortic valve implantation , 2015, Heart.

[11]  M. Leon,et al.  Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis , 2015, Heart.

[12]  L. W. Andersen,et al.  Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.

[13]  R. Lange,et al.  Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. , 2015, Journal of the American College of Cardiology.

[14]  J. Rodés‐Cabau,et al.  Coronary artery disease and transcatheter aortic valve replacement: current treatment paradigms , 2015, Coronary artery disease.

[15]  W. Banya,et al.  Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the U.K. Transcatheter Aortic Valve Implantation Registry. , 2015, JACC. Cardiovascular interventions.

[16]  N. Smedira,et al.  Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. , 2015, The Annals of thoracic surgery.

[17]  M. Mack,et al.  Effect of Tricuspid Regurgitation and the Right Heart on Survival After Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valves II Inoperable Cohort , 2015, Circulation. Cardiovascular interventions.

[18]  John D. Carroll,et al.  Clinical outcomes at 1 year following transcatheter aortic valve replacement. , 2015, JAMA.

[19]  J. Leipsic,et al.  Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[20]  J. Leipsic,et al.  Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. , 2015, JACC. Cardiovascular interventions.

[21]  Philippe Pibarot,et al.  Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. , 2015, JACC. Cardiovascular imaging.

[22]  J. Hendrikse,et al.  Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement. , 2015, The Journal of thoracic and cardiovascular surgery.

[23]  L. Gillam,et al.  Echocardiographic imaging of procedural complications during self-expandable transcatheter aortic valve replacement. , 2015, JACC. Cardiovascular imaging.

[24]  I. Barbash,et al.  Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[25]  M. Mack,et al.  Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. , 2015, European heart journal.

[26]  M. Mack,et al.  Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. , 2014, Journal of the American College of Cardiology.

[27]  P. Wenaweser,et al.  Transcatheter aortic valve replacement in bicuspid aortic valve disease. , 2014, Journal of the American College of Cardiology.

[28]  R. Lange,et al.  Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. , 2014, European heart journal.

[29]  S. Pocock,et al.  Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. , 2014, JACC. Cardiovascular interventions.

[30]  R. Erbel,et al.  Transapical transcatheter aortic valve for severe aortic regurgitation: expanding the limits. , 2014, JACC. Cardiovascular interventions.

[31]  S. de Servi,et al.  CoreValve implantation for severe aortic regurgitation: a multicentre registry. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[32]  M. Leon,et al.  A MULTIDISCIPLINARY, MULTIMODALITY, BUT MINIMALIST (3M) APPROACH TO TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FACILITATES SAFE NEXT DAY DISCHARGE HOME IN HIGH RISK PATIENTS: 1 YEAR FOLLOW UP , 2014 .

[33]  R. Lange,et al.  Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. , 2014, Journal of the American College of Cardiology.

[34]  J. Leipsic,et al.  TCT-701 A Multidisciplinary, Multimodality, but Minimalist (3M) approach to transfemoral transcatheter aortic valve replacement facilitates safe next day discharge home in high risk patients: 1 year follow up , 2014 .

[35]  A. Kastrati,et al.  Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance. , 2014, The Journal of invasive cardiology.

[36]  R. Guyton,et al.  Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. , 2014, JACC. Cardiovascular interventions.

[37]  M. Pasic,et al.  Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. , 2014, JAMA.

[38]  E. Tuzcu,et al.  Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve). , 2014, JACC. Cardiovascular interventions.

[39]  P. Pibarot,et al.  Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. , 2014, Journal of the American College of Cardiology.

[40]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[41]  T. Sundt,et al.  Correction: 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Journal of the American College of Cardiology (2014) 63 (2438-88)) , 2014 .

[42]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[43]  E. Tuzcu,et al.  Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. , 2014, Journal of the American College of Cardiology.

[44]  J. Coselli,et al.  Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. , 2014, Journal of the American College of Cardiology.

[45]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[46]  J. Mehilli,et al.  Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. , 2014, JAMA.

[47]  J. Leipsic,et al.  RATES OF PARAVALVULAR AORTIC REGURGITATION WITH MDCT NOMINAL AREA OVERSIZING OR UNDERSIZING AFTER TRANSCATHETER HEART VALVE REPLACEMENT WITH THE SAPIEN 3: A COMPARISON WITH THE SAPIEN XT , 2014 .

[48]  M. Mack,et al.  Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). , 2014, Journal of the American College of Cardiology.

[49]  R. Whitbourn,et al.  Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[50]  Antonio Colombo,et al.  Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. , 2014, Journal of the American College of Cardiology.

[51]  R. Attia,et al.  Effect of valve design on the stent internal diameter of a bioprosthetic valve: a concept of true internal diameter and its implications for the valve-in-valve procedure. , 2014, JACC. Cardiovascular interventions.

[52]  Martin B. Leon,et al.  Aortic Annular Sizing Using a Novel 3-Dimensional Echocardiographic Method: Use and Comparison With Cardiac Computed Tomography , 2014, Circulation. Cardiovascular imaging.

[53]  Sean M. O'Brien,et al.  Outcomes following transcatheter aortic valve replacement in the United States. , 2013, JAMA.

[54]  M. Leon,et al.  Impact of Preoperative Moderate/Severe Mitral Regurgitation on 2-Year Outcome After Transcatheter and Surgical Aortic Valve Replacement: Insight From the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A , 2013, Circulation.

[55]  Jonathon,et al.  Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. , 2013, Journal of the American College of Cardiology.

[56]  R. Erbel,et al.  Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing. , 2013, JACC. Cardiovascular interventions.

[57]  F. Santini,et al.  Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. , 2013, International journal of cardiology.

[58]  S. Blankenberg,et al.  Bivalvular transcatheter treatment of high-surgical-risk patients with coexisting severe aortic stenosis and significant mitral regurgitation. , 2013, International journal of cardiology.

[59]  G. Feuchtner,et al.  Anatomical and Procedural Features Associated With Aortic Root Rupture During Balloon-Expandable Transcatheter Aortic Valve Replacement , 2013, Circulation.

[60]  P. Jüni,et al.  Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. , 2013, European heart journal.

[61]  J. Bavaria,et al.  Predictors of Mortality and Outcomes of Therapy in Low-Flow Severe Aortic Stenosis: A Placement of Aortic Transcatheter Valves (PARTNER) Trial Analysis , 2013, Circulation.

[62]  Robert H. Anderson,et al.  A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. , 2013, JACC. Cardiovascular interventions.

[63]  Sean M. O'Brien,et al.  Long-Term Safety and Effectiveness of Mechanical Versus Biologic Aortic Valve Prostheses in Older Patients: Results From the Society of Thoracic Surgeons Adult Cardiac Surgery National Database , 2013, Circulation.

[64]  Antonio Colombo,et al.  Clinical ResearchInterventional CardiologyIncidence, Predictors, and Outcomes of Aortic Regurgitation After Transcatheter Aortic Valve Replacement: Meta-Analysis and Systematic Review of Literature , 2013 .

[65]  M. Jahangiri,et al.  Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. , 2013, Journal of the American College of Cardiology.

[66]  G. Dangas,et al.  Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies , 2013, Journal of Thrombosis and Thrombolysis.

[67]  P. Wenaweser,et al.  Atrial Fibrillation and Aortic Stenosis: Impact on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation , 2013, Circulation. Cardiovascular interventions.

[68]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[69]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.

[70]  J. Schofer,et al.  Direct Flow Medical valve. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[71]  D. Wood,et al.  Clinical ResearchInterventional CardiologyTranscatheter Aortic Valve Replacement: Outcomes of Patients With Moderate or Severe Mitral Regurgitation , 2012 .

[72]  F. Mohr,et al.  Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[73]  Scott Lim,et al.  Two-year outcomes after transcatheter or surgical aortic-valve replacement. , 2012, The New England journal of medicine.

[74]  P. Leprince,et al.  Registry of transcatheter aortic-valve implantation in high-risk patients. , 2012, The New England journal of medicine.

[75]  P. Pibarot,et al.  Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. , 2012, JACC. Cardiovascular interventions.

[76]  Eric Durand,et al.  Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. , 2012, JACC. Cardiovascular interventions.

[77]  S. Achenbach,et al.  3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. , 2012, Journal of the American College of Cardiology.

[78]  Cornelius Müller,et al.  Valvular Heart Disease Aortic Regurgitation Index Defines Severity of Peri-Prosthetic Regurgitation and Predicts Outcome in Patients After Transcatheter Aortic Valve Implantation , 2012 .

[79]  N. Bogunovic,et al.  Percutaneous closure of left atrial appendage after transcatheter aortic valve implantation - an interventional approach to avoid anticoagulation therapy in elderly patients: TAVI and closure of LAA to avoid warfarin therapy. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[80]  M. Deutsch,et al.  Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. , 2012, Journal of the American College of Cardiology.

[81]  C. Tamburino,et al.  Percutaneous treatment of aortic stenosis and mitral regurgitation in the same patient , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[82]  R. Madder,et al.  The first report of transcatheter aortic valve implantation and percutaneous mitral valve repair in the same patient. , 2011, JACC. Cardiovascular interventions.

[83]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[84]  Pascal Vranckx,et al.  Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.

[85]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[86]  P. Serruys,et al.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium , 2010, European heart journal.

[87]  Ronen Gurvitch,et al.  Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves , 2010, Circulation.

[88]  Helmut Baumgartner,et al.  Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .

[89]  Philippe Ravaud,et al.  Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? , 2005, European heart journal.

[90]  W. Roberts,et al.  Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation , 2005, Circulation.

[91]  Assaf Bash,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.

[92]  J. Cigarroa,et al.  Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris. , 2001, The American journal of cardiology.

[93]  Roland Hetzer,et al.  Annular rupture during transcatheter aortic valve replacement: classification, pathophysiology, diagnostics, treatment approaches, and prevention. , 2015, JACC. Cardiovascular interventions.

[94]  E. Tuzcu,et al.  Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement. , 2015, JACC. Cardiovascular imaging.

[95]  Pascal Vranckx,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.

[96]  T. Huber,et al.  Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients , 2012 .

[97]  E. Erdmann,et al.  Local versus general anesthesia for transfemoral aortic valve implantation , 2011, Clinical Research in Cardiology.

[98]  M. Mack,et al.  Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. , 2011, The Annals of thoracic surgery.

[99]  M. Bennett,et al.  Through the looking glass. , 2009, Minnesota medicine.